| Cetuximab |
205923-56-4 |
C33H38N4O6.C20H23N7O7.C4H3N2O2F |
| Aflibercept |
845771-78-0 |
|
| Nivolumab |
946414-94-4 |
|
| Glycine |
56-40-6 |
C2H5NO2 |
| 2-Methoxyethylamine |
109-85-3 |
C3H9NO |
| Estriol |
50-27-1 |
C18H24O3 |
| Ibutamoren-mesylate |
159752-10-0 |
C28H40N4O8S2 |
| All trans-Retinal |
116-31-4 |
C20H28O |
| 2,2'-([1,1'-biphenyl]-4,4'-diyldivinylene)bis(benzenesulphonic) acid |
38775-22-3 |
C28H22O6S2 |
| Triarylsulfonium Hexafluoroantimonate Salts in Propylene Carbonate |
109037-75-4 |
C36H28S3+2.C24H19S2+.3[F6Sb-] |
| 2-Amino-3,5-dibromopyrazine |
24241-18-7 |
C4H3N3Br2 |
| 2,4(1H,3H)-Pyrimidinedione, 5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]- |
183204-74-2 |
C9H11ClN4O2 |
| 2,4(1H,3H)-Pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-, hydrochloride (1:1) |
183204-72-0 |
C9H12Cl2N4O2 |
| Cyclohex-2-enol |
822-67-3 |
C6H10O |
| 5-Phenoxyisobenzofuran-1(3H)-one |
57830-14-5 |
C14H10O3 |
| 2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid |
808118-40-3 |
C19H16N2O5 |
| Urolithin M7 |
531512-26-2 |
C13H8O5 |
| Urolithin M6 |
1006683-97-1 |
C13H8O6 |
| Urolithin D |
131086-98-1 |
C13H8O6 |
| 3,3,8,9,10-pentahydroxydibenzo[b,d]pyran-6-one |
91485-02-8 |
C13H8O7 |
